FB Pixel no script
MENU
KrASIA

China

News

HJ Science stumbles in Hong Kong debut after gray market surge

The drug developer has no approved products or revenue yet, but the IPO could extend its cash runway by nearly six years.

6 mins read
  • Some studios are betting on blockbuster ambitions, while others are sticking to lower-risk models that keep returns predictable.

    Insights

    China’s game makers split as giants chase prestige and others target profit

    10 mins read

Most Recent

See All